Related Experiment Video
Updated: Nov 25, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
IgA Vasculitis Nephritis: A Case Series and Comparison of Treatment Guidelines
Abdalhamid Al Harash1, Stephanie Saeli2, Michael Lucke1
1Division of Rheumatology, Department of Medicine, Allegheny Health Network, Pittsburgh, PA, USA.
Abstract:
Immunoglobulin A (IgA) vasculitis nephritis (IgAVN) and IgA nephropathy (IgAN) share many pathological parallels and are viewed as related diseases by many groups. Current treatment guidelines remain vague, controversial, and without consensus, especially regarding the role of immunosuppressive medications. We present five cases of IgAVN encountered at our tertiary care center between 2016 and 2020, which were treated with different immunosuppression regimens. Infection was the leading cause of death in this series. These cases provide evidence that IgAVN should be distinguished from IgAN on a spectrum of IgA-associated glomerulonephritis. The outcomes presented herein suggest that the morbidity and systematic involvement IgAVN is greater than previously believed and that these substantial risks should be reflected in contemporary treatment guidelines.
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Pyelonephritis II: Diagnostic Studies and Management
Nephrotic Syndrome III : Nursing Management
Acute Kidney Injury VI: Nursing Management
Nephrotic Syndrome I : Introduction

